Switzerland-based Sensimed announced it received a de novo FDA clearance for its connected contact lens, Triggerfish, which helps physicians track the progression of glaucoma in patients.
“Although with this approval we have obtained US marketing clearance, our goal for the upcoming months is not to immediately launch the product but rather to work closely with the glaucoma community to design...
